Linbag hard capsules 300 mg. №14

Description

Linbag hard capsules 300 mg Composition
active substance: pregabalin;

1 capsule contains pregabalin 25 mg or 50 mg, 75 mg, 100 mg, or 150 mg, or 200 mg, or 225 mg or 300 mg;

excipients: talc, corn starch, corn starch gelatin capsule: gelatin, titanium dioxide (E 171), iron oxide yellow (E172), iron oxide red (E172) *, iron oxide black (E172) **.

* Not contained in 50 mg capsules.

** Contained in capsules of 25 and 300 mg.

Dosage form
The capsules are hard.

Linbag hard capsules 300 mg Basic physical and chemical properties:

300 mg capsules: size 0 hard gelatin capsules containing white or off-white powder as filling mass. The upper part of the capsule shell (lid): opaque, carmine. The lower part of the capsule shell (body): opaque, pale yellowish brown.

Pharmacotherapeutic group
Antiepileptic drugs. ATX code N03A X16.

Linbag hard capsules 300 mg Pharmacodynamics
The active substance, pregabalin, is an analogue of gamma-aminobutyric acid [(S) -3- (aminomethyl) -5-methylhexanoic acid].

Mechanism of action. Pregabalin binds to an additional subunit (a2-d protein) of potential calcium channels in the central nervous system.

Indications
Neuropathic pain.

Linbag is prescribed for the treatment of neuropathic pain in adults with damage to the peripheral and central nervous systems.

Epilepsy.

Lingbag is prescribed as adjunctive therapy for partial seizures with or without secondary generalization in adults.

Generalized Anxiety Disorder.

Linbag is indicated for the treatment of generalized anxiety disorder in adults.

Contraindications
Hypersensitivity to the active substance or any excipients.